Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLS003 in cutaneous warts
NCT02106260Phase 2Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Mar 2014
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of CLS003 in cutaneous warts, sponsored by Maruho Co., Ltd. Primary endpoints: Area under the plasma concentration versus time curve at 7 days, Number of participants with adverse events at 7 days and 2 more. Started Mar 2014; status: completed.
02
Drugs
CLS003
03
Conditions
cutaneous warts
Beyond the preview
Go deeper on NCT02106260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106260.